NCT06027190 - Randomized Controlled Study of Optical 3D Navigated Repetitive Transcranial Magnetic Stimulation for Achalasia. | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Esophageal AchalasiaTranscranial Magnetic Stimulation, RepetitiveVagus Nerve Motor DisorderFunctional Magnetic Resonance Imaging

Interventions

DEVICE

Repetitive transcranial magnetic stimulation

"Intervention Name and Specification~1. Transcranial magnetic stimulator (M-100 Ultimate, Yingzhi Technology Co., Ltd., China) .~2. 70-mm-diameter figure-of-eight coil (BY90A, Yingzhi Technology Co., Ltd., China). 3) Placebo coil (Magstim Company, Whitland, UK): the appearance and sound were consistent with the true coil, but no current stimulation was produced."

DEVICE

Sham

Placebo coil (Magstim Company, Whitland, UK):

Trial Locations (1)

210008

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors

lead

Zhang Nina

OTHER